Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploration and Validation of Pancreatic Cancer Hub Genes Based on Weighted Gene Co-Expression Network Analysis and Immune Infiltration Score Analysis. | Pharmgenomics Pers Med | 2023 | 37252337 | PubTator, text mining | PubMed |
| The unusual chemical sequences of mammalian dihydropyrimidine dehydrogenase revealed by transient-state analysis. | Methods Enzymol | 2023 | 37245908 | PubTator, text mining | PubMed |
| Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction. | J Pers Med | 2023 | 37240875 | PubTator, text mining | PubMed |
| Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration. | Life (Basel) | 2023 | 37240761 | PubTator, text mining | PubMed |
| A Rodent Model of Human-Dose-Equivalent 5-Fluorouracil: Toxicity in the Liver, Kidneys, and Lungs. | Antioxidants (Basel) | 2023 | 37237871 | PubTator, text mining | PubMed |
| Antifungals: From Pharmacokinetics to Clinical Practice. | Antibiotics (Basel) | 2023 | 37237787 | PubTator, text mining | PubMed |
| Assessment of the Influence of 5-Fluorouracil on SMAD4 and TGFB1 Gene Expression, Apoptosis Induction and DNA Damage in Human Cell Lines. | Bioengineering (Basel) | 2023 | 37237640 | PubTator, text mining | PubMed |
| Genetic spectrum and clinical features of adult leukoencephalopathies in a Chinese cohort. | Ann Clin Transl Neurol | 2023 | 37237429 | PubTator, text mining | PubMed |
| Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer. | ESMO Open | 2023 | 37236086 | PubTator, text mining | PubMed |
| Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center. | Am J Health Syst Pharm | 2023 | 37235983 | PubTator, text mining | PubMed |
| Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data. | Front Pharmacol | 2023 | 37234706 | PubTator, text mining | PubMed |
| Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breast cancer patients. | Pharmacogenomics | 2023 | 37222147 | PubTator, text mining | PubMed |
| Understanding health disparities affecting people of West Central African descent in the United States: An evolutionary perspective. | Evol Appl | 2023 | 37216026 | PubTator, text mining | PubMed |
| Study of Correlation between Serum Osteoprotegerin, TNF-Alfa, and Biomarkers of Bone Metabolism in Patients with Treatment-Naive Graves' Disease-A Cross-Sectional Study. | Indian J Endocrinol Metab | 2023 | 37215268 | PubTator, text mining | PubMed |
| Recurrent cardiotoxicity in a fluoropyrimidine treated cancer patient - case report and practical recommendations. | Arch Clin Cases | 2023 | 37215066 | PubTator, text mining | PubMed |
| PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data. | Nucleic Acids Res | 2023 | 37207338 | PubTator, text mining | PubMed |
Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201. | PLoS One | 2023 | 37205678 | PubTator, text mining | PubMed |
| Individualised prescription of medications for treatment of obesity in adults. | Rev Endocr Metab Disord | 2023 | 37202547 | PubTator, text mining | PubMed |
| Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma. | J Gastrointest Oncol | 2023 | 37201091 | PubTator, text mining | PubMed |
| PHGDH preserves one-carbon cycle to confer metabolic plasticity in chemoresistant gastric cancer during nutrient stress. | Proc Natl Acad Sci U S A | 2023 | 37192160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=26